These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32461067)

  • 21. Famotidine Against SARS-CoV2: A Hope or Hype?
    Ghosh R; Chatterjee S; Dubey S; Lavie CJ
    Mayo Clin Proc; 2020 Aug; 95(8):1797-1799. PubMed ID: 32753153
    [No Abstract]   [Full Text] [Related]  

  • 22. Structural Biology Aids the Research of New Anti-COVID-19 Drugs.
    Lu J; Liu X
    Curr Org Synth; 2020; 17(3):162-163. PubMed ID: 32538717
    [No Abstract]   [Full Text] [Related]  

  • 23. Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions.
    Jogalekar MP; Veerabathini A; Gangadaran P
    Exp Biol Med (Maywood); 2020 Jun; 245(11):964-969. PubMed ID: 32306751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid repurposing of drugs for COVID-19.
    Guy RK; DiPaola RS; Romanelli F; Dutch RE
    Science; 2020 May; 368(6493):829-830. PubMed ID: 32385101
    [No Abstract]   [Full Text] [Related]  

  • 25. Experts Discuss COVID-19-Remdesivir, Vaccines, and More.
    JAMA; 2020 Aug; 324(8):730-731. PubMed ID: 32777002
    [No Abstract]   [Full Text] [Related]  

  • 26. Why not consider an endothelin receptor antagonist against SARS-CoV-2?
    Javor S; Salsano A
    Med Hypotheses; 2020 Aug; 141():109792. PubMed ID: 32361169
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug Discovery Strategies for SARS-CoV-2.
    Shyr ZA; Gorshkov K; Chen CZ; Zheng W
    J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 in the Eastern Mediterranean Region and Saudi Arabia: prevention and therapeutic strategies.
    Al-Tawfiq JA; Memish ZA
    Int J Antimicrob Agents; 2020 May; 55(5):105968. PubMed ID: 32259576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19: Some clinical questions after the first 4 months.
    Bassetti M; Ansaldi F; Icardi G; Pelosi P; Robba C; Taramasso L; Trucchi C; Vena A; Giacobbe DR
    Eur J Clin Invest; 2020 Jul; 50(7):e13326. PubMed ID: 32562550
    [No Abstract]   [Full Text] [Related]  

  • 30. Current and future therapeutical approaches for COVID-19.
    Duan Y; Yao Y; Kumar SA; Zhu HL; Chang J
    Drug Discov Today; 2020 Aug; 25(8):1545-1552. PubMed ID: 32574697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms Underlying Potential Therapeutic Approaches for COVID-19.
    Benani A; Ben Mkaddem S
    Front Immunol; 2020; 11():1841. PubMed ID: 32793246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Favipiravir, an antiviral for COVID-19?
    Coomes EA; Haghbayan H
    J Antimicrob Chemother; 2020 Jul; 75(7):2013-2014. PubMed ID: 32417899
    [No Abstract]   [Full Text] [Related]  

  • 33. COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
    White NJ; Watson JA; Hoglund RM; Chan XHS; Cheah PY; Tarning J
    PLoS Med; 2020 Sep; 17(9):e1003252. PubMed ID: 32881895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sofosbuvir for COVID-19 infection: A potential candidate.
    Gupta R; Dhamija P
    Indian J Pharmacol; 2020; 52(3):232-233. PubMed ID: 32874010
    [No Abstract]   [Full Text] [Related]  

  • 35. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Mar; 16(685):510-511. PubMed ID: 32167254
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of Potential Therapeutic Options for COVID-19.
    Austin D; Okour M
    J Clin Pharmacol; 2020 Aug; 60(8):976-977. PubMed ID: 32469418
    [No Abstract]   [Full Text] [Related]  

  • 37. Medication therapy strategies for the coronavirus disease 2019 (COVID-19): recent progress and challenges.
    Yang X; Liu Y; Liu Y; Yang Q; Wu X; Huang X; Liu H; Cai W; Ma G
    Expert Rev Clin Pharmacol; 2020 Sep; 13(9):957-975. PubMed ID: 32746653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statin therapy and SAR-COV-2: an available and potential therapy?
    Abdel-Latif RG; Mohammed S; Elgendy IY
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):333-334. PubMed ID: 32379307
    [No Abstract]   [Full Text] [Related]  

  • 39. Metabolomics to Predict Antiviral Drug Efficacy in COVID-19.
    Migaud M; Gandotra S; Chand HS; Gillespie MN; Thannickal VJ; Langley RJ
    Am J Respir Cell Mol Biol; 2020 Sep; 63(3):396-398. PubMed ID: 32574504
    [No Abstract]   [Full Text] [Related]  

  • 40. News Feature: To counter the pandemic, clinicians bank on repurposed drugs.
    Madhusoodanan J
    Proc Natl Acad Sci U S A; 2020 May; 117(20):10616-10620. PubMed ID: 32350142
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.